Published in Clin Pharmacol Ther on November 30, 2011
Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment. J Infect Dis (2013) 0.93
Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD. Nat Commun (2013) 0.93
Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency. Nat Commun (2016) 0.92
Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi. Proc Natl Acad Sci U S A (2015) 0.87
Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung. Pharmaceuticals (Basel) (2012) 0.82
Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Dermatol Ther (Heidelb) (2013) 0.81
Genome-guided discovery of diverse natural products from Burkholderia sp. J Ind Microbiol Biotechnol (2013) 0.80
Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review). Exp Ther Med (2014) 0.79
The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation. PLoS One (2015) 0.78
Roflumilast: a review of its use in the treatment of COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.78
Roflumilast partially reverses smoke-induced mucociliary dysfunction. Respir Res (2015) 0.76
Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review. Respir Res (2016) 0.76
Effect of a Dose-Escalation Regimen for Improving Adherence to Roflumilast in Patients with Chronic Obstructive Pulmonary Disease. Tuberc Respir Dis (Seoul) (2015) 0.75
Laminin--a glycoprotein from basement membranes. J Biol Chem (1979) 12.49
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985) (1986) 6.86
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med (1984) 3.73
Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein. Lab Invest (1980) 3.64
Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci U S A (1980) 3.57
Chicken soup inhibits neutrophil chemotaxis in vitro. Chest (2000) 3.48
Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem (1980) 3.28
Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA (1994) 3.03
New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet (1980) 2.35
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med (1984) 2.30
Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry (1986) 2.28
Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest (1981) 2.20
Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med (1997) 2.12
Antibodies to laminin in Chagas' disease. J Exp Med (1982) 2.11
Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med (1986) 1.90
Three efflux pumps are required to provide efficient tolerance to toluene in Pseudomonas putida DOT-T1E. J Bacteriol (2001) 1.88
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest (1986) 1.82
Neutrophil chemotactic factors in bacterial pneumonia. Chest (1989) 1.69
Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med (1990) 1.67
Pulmonary macrophages can stimulate cell growth of bovine bronchial epithelial cells. Am J Respir Cell Mol Biol (1990) 1.66
Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis (1984) 1.64
Role of fibronectin as a growth factor for fibroblasts. J Cell Biol (1983) 1.64
Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J Clin Invest (1984) 1.61
Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis (1989) 1.58
Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis (1987) 1.57
Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. JAMA (1997) 1.56
Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol (2001) 1.55
Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis (1991) 1.49
Neutrophilic respiratory tract inflammation and peripheral blood neutrophilia after grain sorghum dust extract challenge. Chest (1995) 1.42
The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med (1999) 1.42
Procollagen production and procollagen messenger RNA levels and activity in human lung fibroblasts during periods of rapid and stationary growth. J Biol Chem (1981) 1.41
Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med (1983) 1.38
Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch Intern Med (1991) 1.38
Regional distribution of emphysema: correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology (1992) 1.36
Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest (1982) 1.31
Regulation of fibroblast proliferation in three-dimensional collagen gel matrix. In Vitro Cell Dev Biol Anim (1997) 1.28
Acetaldehyde-stimulated PKC activity in airway epithelial cells treated with smoke extract from normal and smokeless cigarettes. Proc Soc Exp Biol Med (2000) 1.25
Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res (1999) 1.22
Immunological functions of the pulmonary epithelium. Eur Respir J (1995) 1.22
Smoke and viral infection cause cilia loss detectable by bronchoalveolar lavage cytology and dynein ELISA. Am J Respir Crit Care Med (1994) 1.21
Blunt abdominal trauma in head injuries. Lancet (1966) 1.21
Hormonal requirements for basement membrane collagen deposition by cultured rat mammary epithelium. Lab Invest (1979) 1.20
Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis (1985) 1.20
Transplanted BM and BM side population cells contribute progeny to the lung and liver in irradiated mice. Cytotherapy (2003) 1.19
Effect of collagen and cell shape on binding of fibronectin to cells. Arch Biochem Biophys (1981) 1.18
Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. Am J Respir Crit Care Med (1995) 1.13
Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. Am J Pathol (1985) 1.13
Total indoor smoking ban and smoker behavior. Prev Med (1992) 1.12
Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia. Am J Med (1993) 1.12
A model clinic approach to the reproductive health concerns of the mentally handicapped. Obstet Gynecol (1986) 1.12
Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med (1991) 1.12
Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. Am Rev Respir Dis (1991) 1.11
Paraquat-induced pulmonary fibrosis. Role of the alveolitis in modulating the development of fibrosis. Am Rev Respir Dis (1984) 1.11
Preparation of collagen substrates for cell attachment: effect of collagen concentration and phosphate buffer. Anal Biochem (1979) 1.09
Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am J Respir Cell Mol Biol (2001) 1.08
Complement activation by cigarette smoke. Am J Physiol (1991) 1.08
NIH conference. Airway inflammation. Ann Intern Med (1995) 1.08
Adhesion characteristics of murine metastatic and nonmetastatic tumor cells in vitro. Cancer Res (1980) 1.07
The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr Opin Pulm Med (1999) 1.07
Contraction of fibroblast-containing collagen gels: initial collagen concentration regulates the degree of contraction and cell survival. In Vitro Cell Dev Biol Anim (2001) 1.04
An enzyme-linked immunoassay for the cartilage proteoglycan. Arch Biochem Biophys (1981) 1.04
Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis (1992) 1.04
Pathogenesis, evaluation, and therapy for massive hemoptysis. Clin Chest Med (1992) 1.02
Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE(2) and NO acting through separate parallel pathways. Am J Respir Cell Mol Biol (2001) 1.02
Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels. Respir Res (2001) 1.02
The Goodpasture-like syndrome in mice induced by intravenous injections of anti-type IV collagen and anti-laminin antibody. Am J Pathol (1982) 1.01
Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. Am J Physiol (1998) 1.01
Cyclooxygenase metabolites are compartmentalized in the human lower respiratory tract. J Appl Physiol (1985) (1987) 1.00
Respiratory tract responses to dust: relationships between dust burden, lung injury, alveolar macrophage fibronectin release, and the development of pulmonary fibrosis. Toxicol Appl Pharmacol (1990) 0.99
Synergistic neutrophil elastase-cytokine interaction degrades collagen in three-dimensional culture. Am J Physiol Lung Cell Mol Physiol (2001) 0.98
Candidate genes for COPD in two large data sets. Eur Respir J (2010) 0.96
Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol (1992) 0.95
Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med (1993) 0.95
Organic dust toxic syndrome: an acute febrile reaction to organic dust exposure distinct from hypersensitivity pneumonitis. J Toxicol Clin Toxicol (1990) 0.95
Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema. Am Rev Respir Dis (1990) 0.94
Two-colour flow-cytometric analysis of pulmonary alveolar macrophages from smokers. Eur Respir J (1999) 0.94
Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells. Am J Physiol (1997) 0.94
Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group. Arch Fam Med (1998) 0.93
Role of peptidases in bradykinin-induced increase in vascular permeability in vivo. Circ Res (1992) 0.93
Persistence of TGF-beta1 induction of increased fibroblast contractility. In Vitro Cell Dev Biol Anim (2001) 0.93
Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke. J Immunol (1998) 0.93
Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor. Am Rev Respir Dis (1984) 0.93
Bronchial epithelial cells produce lung fibroblast chemotactic factor: fibronectin. Am J Respir Cell Mol Biol (1989) 0.92
Retinoic acid attenuates cytokine-driven fibroblast degradation of extracellular matrix in three-dimensional culture. Am J Respir Cell Mol Biol (2001) 0.92
Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Respir Dis (1984) 0.92
Gcglobulin functions as a cochemotaxin in the lower respiratory tract. A potential mechanism for lung neutrophil recruitment in cigarette smokers. Am Rev Respir Dis (1991) 0.92
Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest (1990) 0.92
Modification of type I collagenous gels by alveolar epithelial cells. Am J Respir Cell Mol Biol (2000) 0.92
Modulation of fibronectin production of bovine bronchial epithelial cells by transforming growth factor-beta. Am J Respir Cell Mol Biol (1992) 0.92
Cell-matrix and cell-cell interactions modulate apoptosis of bronchial epithelial cells. Am J Physiol (1997) 0.92
Bronchial epithelial cells release chemoattractant activity for monocytes. Am J Physiol (1989) 0.92
Cellular and metabolic specificity in the interaction of adhesion proteins with collagen and with cells. J Supramol Struct (1979) 0.91
Effects of cigarette smoke extract on bovine bronchial epithelial cell attachment and migration. Am J Physiol (1995) 0.91
IL-4 induces ICAM-1 expression in human bronchial epithelial cells and potentiates TNF-alpha. Am J Physiol (1999) 0.91